The Hungarian government has decided to award Israeli drug maker Teva a Ft 2 billion subsidy for a $100-million capacity expansion at its tablet plant in Debrecen.
The announcement was made by Economy Minister Csaba Kákosy and Teva Magyarország CEO András Rózsa said at a press conference in Budapest on Monday. The capacity expansion will create 415 new workplaces. Teva will double its capacity at the plant to an annual 15 billion as a result of the investment, which will be completed in 2010, Teva Gyógyszergyártó Lajos Hegedűs said. Debrecen mayor Lajos Kósa announced that the local council gave Teva’s investment a preferential treatment due to its high value added and allow Teva to reduce its Local Business Tax base with some of its costs. (Gazdasági Rádió, Napi Gazdaság)
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.